Kaleido Biosciences | Evaluate

October 05, 2021

Vedanta makes Clostridioides difficile look easy

US shutdown dampens first-quarter flotations

Biopharma IPOs dipped in the opening months of 2019, but numbers look fairly healthy despite January's US government closure.

July 09, 2018

The venture money keeps flowing for biopharma

Private drug developers raised a record $8.5bn in the first half of 2018, amid a surge in mega rounds.